JUN and melanoma: Notably, siRNA knockdown of Jun resulted in a significant decrease of PD-L1 in melanoma cell lines [82] and reduced Jun expression using a novel Jun inhibitor, ailanthone, suppressed melanoma progression and inhibition of regulatory T cell (Treg) infiltration [105].